Quetiapine efficacy in bipolar depression study - QUEEN

Study identifier:NIS-NKR-SER-2007/2

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A 8-week, Multicenter, Open-label, Observational study of the efficacy of Quetiapine Fumarate (SEROQUEL) Immediate-release tablets in adult patients with bipolar depression

Medical condition

bipolar depression

Phase

-

Healthy volunteers

No

Study drug

-

Sex

All

Actual Enrollment

2000

Study type

Observational

Age

18 Years - 65 Years

Date

Study Start Date: 01 Jun 2007
Primary Completion Date: 01 Oct 2007
Study Completion Date: 01 Dec 2007

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria